Trial
NCT03332524
Clinical Trial of the Safety and Efficacy of SP160412 in the Temporary Relief of Mild to Moderate Sunburn
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Sephoris Pharmaceuticals LLC
Collaborators
—
Condition
Sunburn
Intervention
SP160412 Ibuprofen 400 mg and Chlorpheniramine maleate 4 mg
Why stopped
Sponsor decided to stop for lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-27